Why Illumina’s investment in MyOme could reset expectations for genome-based prevention

Why Illumina’s investment in MyOme could reset expectations for genome-based prevention

Illumina, Inc. and MyOme, Inc. have announced a new strategic collaboration, including an equity investment by Illumina to support MyOme’s upcoming Proactive Health (MPH) Trial. The large-scale clinical study, expected to begin in 2026, will evaluate the impact of artificial intelligence-integrated whole-genome sequencing on chronic disease prevention and cost savings across the U.S. healthcare system. […]

What Pillar Biosciences’ China move means for decentralized oncology diagnostics

What Pillar Biosciences’ China move means for decentralized oncology diagnostics

Pillar Biosciences has expanded its collaboration with AstraZeneca to bring its next-generation sequencing-based liquid biopsy kits to China, aiming to accelerate localized tumor profiling and broaden access to precision oncology diagnostics. The partnership, which includes Shanghai Zhengu Biological Technology Co., Ltd., is designed to support assay implementation across Chinese hospital laboratories to reduce diagnostic turnaround […]

Is InstaMed’s oral peptide strip the needle-free breakthrough peptide delivery has been waiting for?

Is InstaMed’s oral peptide strip the needle-free breakthrough peptide delivery has been waiting for?

InstaMed Pharmaceuticals has reported rapid commercial traction for its InstaRelease oral dissolving strip, a patented non-injectable peptide delivery technology. The company announced a 300 percent month-over-month sales increase since its May 2025 launch and shared results from a double-blind pharmacokinetic study validating buccal absorption of glutathione as an effective alternative to traditional injection. The platform […]

Can Peijia Medical’s TaurusTrio system finally solve the AR treatment gap in China?

Can Peijia Medical’s TaurusTrio system finally solve the AR treatment gap in China?

Peijia Medical has received regulatory approval from the National Medical Products Administration of China for the TaurusTrio Transcatheter Aortic Valve system, a dedicated device for the treatment of native symptomatic severe aortic regurgitation. Developed under an exclusive license from JenaValve Technology, the system is based on the latter’s Trilogy Transcatheter Heart Valve platform and represents […]

Can Roivios’ JuxtaFlow device redefine kidney support in heart failure and cardiac surgery patients?

Can Roivios’ JuxtaFlow device redefine kidney support in heart failure and cardiac surgery patients?

Roivios Ltd., a clinical-stage medical device developer, has announced encouraging results from its first-in-human study of the JuxtaFlow Renal Assist Device, a technology designed to support fluid removal and renal function in patients with diuretic-resistant cardiorenal syndrome and acute decompensated heart failure. The results, published in the ASAIO Journal, showed that JuxtaFlow significantly improved both […]

How KVP International’s SafePath-IVD buy could reshape veterinary and human diagnostics

How KVP International’s SafePath-IVD buy could reshape veterinary and human diagnostics

KVP International has announced the acquisition of SafePath Laboratories and IVD Research, a diagnostics manufacturer and contract development and manufacturing organization (CDMO) provider headquartered in Carlsbad, California. With this move, KVP International aims to strengthen its footprint in veterinary diagnostics while unlocking the potential to expand into human health markets. This acquisition provides KVP International […]

Can Sanyou Biopharmaceuticals and KanryBio Biotechnology disrupt the global companion diagnostics market?

Can Sanyou Biopharmaceuticals and KanryBio Biotechnology disrupt the global companion diagnostics market?

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. and Wenzhou KanryBio Biotechnology Co., Ltd. have entered into a strategic collaboration focused on co-developing high-value reagents and products for biomarker assay kits. Announced on December 10, 2025, this partnership aims to combine Sanyou Biopharmaceuticals’ global leadership in AI-driven molecular discovery with KanryBio Biotechnology’s capabilities in kit product development and […]

Will the TricValve pivotal trial finally solve the unmet needs in severe tricuspid regurgitation?

Will the TricValve pivotal trial finally solve the unmet needs in severe tricuspid regurgitation?

P&F Products and Features GmbH, the Austria-based cardiovascular device innovator, has secured approval from the U.S. Food and Drug Administration to initiate the TRICAV II pivotal clinical trial. The study will evaluate the TricValve Transcatheter Bicaval Valve System for severe tricuspid regurgitation, aiming to provide a minimally invasive option for patients who currently have no […]